Mark Fletcher joins board to promote growth and drive strategic partnerships
"I am excited to welcome Mark Fletcher as an Independent Director to our Board, a long-time friend and advisor," says Jackie Vestevich, Xoran's Executive Chairman. "Xoran is poised for growth and Mark Fletcher brings impressive accomplishments, experience, and expertise in various med device markets that will supercharge our drive to make meaningful improvements to patient care in human and veterinary medicine. I'm confident Mark will make an immediate, positive impact on our organizational goals."
Mark Fletcher brings to Xoran's Board years of experience and expertise in developing high growth MedTech and med device businesses that span various medical enterprises. Fletcher previously held the role of President and CEO at Katena Medical; President, Surgical Technologies at Medtronic Plc; Vice President of Sales and Marketing at Xomed Surgical Products; and Vice President at Stryker Corporation. He currently serves as Chairman, Neurent Medical, Galway, Ireland.
"Mark's experience in successfully guiding MedTech companies has uniquely prepared him to help Xoran advance to the next level," says Misha Rakic, Xoran's CEO. "With the addition of his strategic guidance, Xoran is positioned to continue to make a significant impact on the healthcare sector."
"I'm excited to join Xoran's Board of Managers and build on the organization's strategic direction," says Fletcher. "Our focus will center on the clinical and economic benefits of point-of-care
Source: Xoran Technologies
